Novocure

Novocure SEC Form 8-K Discloses Material Network Breach Exposing Oncology Device Systems and Clinical Records

Oncology medical technology leader Novocure files SEC Form 8-K Item 1.05 disclosing an unauthorized intrusion compromising clinical data and IT infrastructure.